MicuRx shareholders Genie Pharma publicly solicit votes to oppose certain proposals
I'm PortAI, I can summarize articles.
MicuRx's shareholder Genie Pharma voted against several proposals for the second extraordinary general meeting in 2025, holding 71.5728 million shares, accounting for 10.92% of the total shares. The solicitation period for voting rights is from September 25, 2025, to October 6, 2025. Reasons for opposition include the uncertainty of funds from Haiqing Pharmaceutical's private placement, risks of mixed sales channels, and the progress of fundraising projects not meeting expectations
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments